Specifically, CADPS downregulation has been observed in high-grade serous ovarian cancer [16], cholangiocarcinoma [17], and hepatocellular carcinoma [18], suggesting a conserved tumor-suppressive function across malignancies. The gene discussed is CADPS; the disease is neoplasm.